Adjuvant capecitabine in biliary tract cancer: a standard option?

被引：25
|
作者：
Malka, David [1 ]
Edeline, Julien [2 ]
机构：
[1] Univ Paris Saclay, Gustave Roussy, Dept Canc Med, Villejuif, France
[2] Ctr Eugene Marquis, Dept Med Oncol, Rennes, France
来源：
LANCET ONCOLOGY | 2019年 / 20卷 / 05期
关键词：
GEMCITABINE; CHEMOTHERAPY; TRIAL;
D O I：
10.1016/S1470-2045(19)30022-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：606 / 608
页数：4
相关论文
共 50 条
  • [1] Capecitabine: Still a Standard Option in the Adjuvant Setting of Biliary Tract Cancer?
    Edeline, Julien
    Malka, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (31) : 3667 - +
  • [2] ADJUVANT CAPECITABINE: A NEW STANDARD OF CARE IN BILIARY TRACT CANCER
    Lamarca, Angela
    Gambardella, Valentina
    Cejalvo, Juan-Miguel
    Fleitas-Kanonnikoff, Tania
    Cervantes, Andres
    [J]. ESMO OPEN, 2019, 4 (03)
  • [3] BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care
    Rizzo, Alessandro
    Brandi, Giovanni
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 15 (05) : 483 - 485
  • [4] Reevaluating Adjuvant Capecitabine for Resected Biliary Tract Cancer
    Benjamin, David J.
    Prasad, Vinay
    [J]. ONCOLOGIST, 2024, 29 (02): : 100 - 101
  • [5] Adjuvant capecitabine for biliary tract cancer: The BILCAP randomized study.
    Primrose, John Neil
    Fox, Richard
    Palmer, Daniel H.
    Prasad, Raj
    Mirza, Darius
    Anthoney, David Alan
    Corrie, Philippa
    Falk, Stephen
    Wasan, Harpreet Singh
    Ross, Paul J.
    Wall, Lucy R.
    Wadsley, Jonathan
    Evans, T. R. Jeffry
    Stocken, Deborah
    Praseedom, Raaj
    Cunningham, David
    Garden, O. James
    Stubbs, Clive
    Valle, Juan W.
    Bridgewater, John A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Combined versus sequential adjuvant therapy of biliary tract cancer: What is the best option?
    Cassano, Alessandra
    Mattiucci, Gian Carlo
    Cerchiaro, Eleonora
    Di Noia, Vincenzo Pio
    Autorino, Rosa
    De Filippo, Laura
    Strippoli, Antonia
    Dadduzio, Vincenzo
    Rossi, Sabrina
    Larocca, Mario
    Campitiello, Marco
    Ramundo, Matteo
    Ardito, Francesco
    Basso, Michele
    Giuliante, Felice
    Valentini, Vincenzo
    Barone, Carlo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] Adjuvant treatment in biliary tract cancer
    Palloni, Andrea
    Frega, Giorgio
    De Lorenzo, Stefania
    Rizzo, Alessandro
    Abbati, Francesca
    Deserti, Marzia
    Tavolari, Simona
    Brandi, Giovanni
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S289 - S296
  • [8] Adjuvant therapy for biliary tract cancer
    Bridgewater, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 57 : S2 - S2
  • [9] ADJUBIL: A phase II study of immunotherapy with durvalumab and tremelimumab in combination with capecitabine or without capecitabine in adjuvant situation for biliary tract cancer
    Goetze, Thorsten Oliver
    Kochen, Lisa
    Vortmeyer, Doerthe
    Al-Batran, Salah-Eddin
    Habibzada, Timorshah
    Brunner, Marius
    Ettrich, Thomas Jens
    Gonzalez-Carmona, Maria A.
    Kohne, Claus-Henning
    Modest, Dominik Paul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] ADJUBIL: A phase II study of immunotherapy with durvalumab and tremelimumab in combination with capecitabine or without capecitabine in adjuvant situation for biliary tract cancer.
    Goetze, Thorsten
    Eickhoff, Regina
    Pons, Miriam
    Kochen, Lisa
    Vortmeyer, Doerthe
    Al-Batran, Salah-Eddin
    Habibzade, Timursah
    Adler, Marius
    Gonzalez-Carmona, Maria A.
    Ettrich, Thomas Jens
    Koehne, Claus-Henning
    Pink, Daniel
    van Boemmel, Florian
    Pession, Ursula
    Wehler, Thomas
    Modest, Dominik Paul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS583 - TPS583
12345